These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25140878)

  • 1. Elevated heart rate triggers action potential alternans and sudden death. translational study of a homozygous KCNH2 mutation.
    Schweigmann U; Biliczki P; Ramirez RJ; Marschall C; Takac I; Brandes RP; Kotzot D; Girmatsion Z; Hohnloser SH; Ehrlich JR
    PLoS One; 2014; 9(8):e103150. PubMed ID: 25140878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
    Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular properties of C-terminal KCNH2 long QT syndrome mutations: description and divergence from clinical phenotypes.
    Biliczki P; Girmatsion Z; Harenkamp S; Anneken L; Brandes RP; Varro A; Marschall C; Herrera D; Hohnloser SH; Nattel S; Ehrlich JR
    Heart Rhythm; 2008 Aug; 5(8):1159-67. PubMed ID: 18675227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of ion channel gene variants in patients with long QT syndrome.
    Ernesto C; Cruz FE; Lima FS; Coutinho JL; Silva R; Urményi TP; Carvalho AC; Rondinelli E
    Arq Bras Cardiol; 2011 Mar; 96(3):172-8. PubMed ID: 21308345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A missense mutation (G604S) in the S5/pore region of HERG causes long QT syndrome in a Chinese family with a high incidence of sudden unexpected death.
    Zhang Y; Zhou N; Jiang W; Peng J; Wan H; Huang C; Xie Z; Huang CL; Grace AA; Ma A
    Eur J Pediatr; 2007 Sep; 166(9):927-33. PubMed ID: 17171344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
    Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
    Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency.
    Paulussen AD; Raes A; Jongbloed RJ; Gilissen RA; Wilde AA; Snyders DJ; Smeets HJ; Aerssens J
    Cardiovasc Res; 2005 Aug; 67(3):467-75. PubMed ID: 15958262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome.
    Liu L; Hayashi K; Kaneda T; Ino H; Fujino N; Uchiyama K; Konno T; Tsuda T; Kawashiri MA; Ueda K; Higashikata T; Shuai W; Kupershmidt S; Higashida H; Yamagishi M
    Heart Rhythm; 2013 Jan; 10(1):61-7. PubMed ID: 23010577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and clinical characterization of a novel homozygous KCNH2 missense variant in the pore region of Kv11.1 leading to a viable but severe long-QT syndrome.
    Delinière A; Jaupart L; Janin A; Millat G; Boulin T; Andrini O; Chevalier P
    Gene; 2024 Mar; 897():148076. PubMed ID: 38086455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.
    Cordeiro JM; Perez GJ; Schmitt N; Pfeiffer R; Nesterenko VV; Burashnikov E; Veltmann C; Borggrefe M; Wolpert C; Schimpf R; Antzelevitch C
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1181-90. PubMed ID: 21164565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
    Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
    PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined gating and trafficking defect in Kv11.1 manifests as a malignant long QT syndrome phenotype in a large Danish p.F29L founder family.
    Kanters JK; Skibsbye L; Hedley PL; Dembic M; Liang B; Hagen CM; Eschen O; Grunnet M; Christiansen M; Jespersen T
    Scand J Clin Lab Invest; 2015; 75(8):699-709. PubMed ID: 26403377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome.
    Fukumoto D; Ding WG; Wada Y; Fujii Y; Ichikawa M; Takayama K; Fukuyama M; Kato K; Itoh H; Makiyama T; Omatsu-Kanbe M; Matsuura H; Horie M; Ohno S
    J Cardiol; 2018 Apr; 71(4):401-408. PubMed ID: 29146210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.
    Barsheshet A; Moss AJ; McNitt S; Polonsky S; Lopes CM; Zareba W; Robinson JL; Ackerman MJ; Benhorin J; Kaufman ES; Towbin JA; Vincent GM; Qi M; Goldenberg I
    Circ Cardiovasc Genet; 2011 Oct; 4(5):491-9. PubMed ID: 21831960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns.
    Piippo K; Laitinen P; Swan H; Toivonen L; Viitasalo M; Pasternack M; Paavonen K; Chapman H; Wann KT; Hirvelä E; Sajantila A; Kontula K
    J Am Coll Cardiol; 2000 Jun; 35(7):1919-25. PubMed ID: 10841244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases.
    Winkel BG; Larsen MK; Berge KE; Leren TP; Nissen PH; Olesen MS; Hollegaard MV; Jespersen T; Yuan L; Nielsen N; Haunsø S; Svendsen JH; Wang Y; Kristensen IB; Jensen HK; Tfelt-Hansen J; Banner J
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1092-8. PubMed ID: 22882672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.
    Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK
    BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of
    Zhou W; Ye D; Tester DJ; Bains S; Giudicessi JR; Haglund-Turnquist CM; Orland KM; January CT; Eckhardt LL; Maginot KR; Ackerman MJ
    Circ Genom Precis Med; 2023 Apr; 16(2):e003726. PubMed ID: 37071726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death.
    Nof E; Cordeiro JM; Pérez GJ; Scornik FS; Calloe K; Love B; Burashnikov E; Caceres G; Gunsburg M; Antzelevitch C
    Circ Cardiovasc Genet; 2010 Apr; 3(2):199-206. PubMed ID: 20181576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.
    Crotti L; Lundquist AL; Insolia R; Pedrazzini M; Ferrandi C; De Ferrari GM; Vicentini A; Yang P; Roden DM; George AL; Schwartz PJ
    Circulation; 2005 Aug; 112(9):1251-8. PubMed ID: 16116052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.